Biomarker Qualification Pathways: A Perspective on Why Promising Markers Stall Before Regulatory Acceptance. Translational Medicine & Therapeutics Journal, [S. l.], v. 1, n. 1, p. 46–55, 2022. DOI: 10.5281/zenodo.22648855. Disponível em: https://inkwise.org/index.php/TMTJ/article/view/69. Acesso em: 5 nov. 2026.